$MDXH
MDxHealth SA
CIK:0001872529|SEC Filings
Consolidated Statement of Profit or Loss - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Profit or loss [abstract] | |||
| Revenues | $ 107,875 | $ 90,049 | $ 70,193 |
| Cost of sales (exclusive of amortization of intangible assets) | (38,242) | (34,908) | (26,264) |
| Gross profit | 69,633 | 55,141 | 43,929 |
| Research and development expenses | (10,350) | (10,552) | (6,376) |
| Selling and marketing expenses | (42,564) | (40,981) | (36,915) |
| General and administrative expenses | (26,928) | (22,801) | (23,010) |
| Amortization of intangible assets | (5,192) | (4,905) | (4,494) |
| Other operating income (expense), net | 993 | (624) | (461) |
| Operating loss | (14,408) | (24,722) | (27,327) |
| Financial income | 2,062 | 2,357 | 2,570 |
| Financial expenses | (23,030) | (15,322) | (18,342) |
| Loss before income tax | (35,376) | (37,687) | (43,099) |
| Income tax benefit (expense) | 1,857 | (382) | (1) |
| Loss for the year attributable to owners of the parent | $ (33,519) | $ (38,069) | $ (43,100) |
| Loss per share attributable to owners of the parent | |||
| Basic (in Dollars per share) | $ (0.67) | $ (1.16) | $ (1.66) |
| Diluted (in Dollars per share) | $ (0.67) | $ (1.16) | $ (1.66) |